Co-Diagnostics, Inc.
CODXNASDAQHealthcare● Active
$5.01
$-0.04(-0.79%)
Market Cap$5592392
P/E Ratio—
52W High$46.5
52W Low$1.26
Co-Diagnostics, Inc. (CODX) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CODX · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($46.90M) | ($37.64M) | ($35.33M) | ($14.24M) | $36.66M |
| Depreciation & Amort. | $1.11M | $1.38M | $1.23M | $1.28M | $0.34M |
| Stock-Based Comp. | $2.25M | $5.43M | $8.34M | $7.54M | $5.51M |
| Change in Working Capital | ($3.17M) | $2.75M | $5.64M | $6.19M | ($2.90M) |
| Net Cash from Operations | ($29.14M) | ($29.16M) | ($22.08M) | $6.57M | $41.08M |
| Investing Activities | |||||
| Capital Expenditure | ($0.70M) | ($0.75M) | ($1.37M) | ($1.43M) | ($0.67M) |
| Purchases of Investments | ($6.59M) | ($40.80M) | ($110.50M) | ($68.00M) | $0.00M |
| Sales of Investments | $33.67M | $58.77M | $127.25M | $11.26M | $3.08M |
| Net Cash from Investing | $26.27M | $17.07M | $15.39M | ($58.17M) | $4.10M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($1.36M) | ($14.21M) | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $11.81M | $0.10M | ($1.36M) | ($14.03M) | $0.45M |
| Free Cash Flow | |||||
| Free Cash Flow | ($29.84M) | ($29.90M) | ($23.45M) | $5.14M | $40.41M |
| FCF Margin %(computed) | — | -763.78% | -344.20% | 15.02% | 41.28% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Co-Diagnostics, Inc. data
About Co-Diagnostics, Inc. (CODX) Cash Flow Statement
Co-Diagnostics, Inc. generated operating cash flow of ($0.03B) and free cash flow of ($0.03B) for 2025 — a FCF margin of -4793.17%. Capital expenditure was ($0.00B).
Frequently asked questions
CODX · 4 questionsCo-Diagnostics, Inc. generated free cash flow of ($0.03B) for 2025, up 0.2% year-over-year.
CODX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10